Immunotherapy for multiple myeloma: new chances and hope

被引:0
作者
Xu, Jingyu [1 ,2 ,3 ]
An, Gang [1 ,2 ,3 ]
Qiu, Lugui [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China
[3] Tianjin Inst Hlth Sci, Tianjin 301600, Peoples R China
基金
中国国家自然科学基金;
关键词
T-CELL THERAPY; CILTA-CEL; RECEPTOR;
D O I
10.20892/j.issn.2095-3941.2023.0258
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:695 / 700
页数:6
相关论文
共 50 条
[21]   Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: US Myeloma Immunotherapy Consortium Real- World Experience [J].
Khouri, Jack ;
Dima, Danai ;
Li, Hong ;
Hansen, Doris ;
Sidana, Surbhi ;
Shune, Leyla ;
Anwer, Faiz ;
Sborov, Douglas ;
Wagner, Charlotte ;
Kocoglu, Mehmet H. ;
Atrash, Shebli ;
Voorhees, Peter ;
Peres, Lauren ;
Hovanky, Vanna ;
Simmons, Gary ;
Williams, Louis ;
Raza, Shahzad ;
Afrough, Aimaz ;
Anderson, Larry D. ;
Ferreri, Christopher ;
Hashmi, Hamza ;
Davis, James ;
McGuirk, Joseph ;
Goldsmith, Scott ;
Borogovac, Azra ;
Lin, Yi ;
Midha, Shonali ;
Nadeem, Omar ;
Locke, Frederick L. ;
Baz, Rachid ;
Hamilton, Betty ;
Alsina, Melissa ;
Sauter, Craig ;
Patel, Krina ;
Kaur, Gurbakhash .
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (08) :790.e1-790.e16
[22]   A new decade: novel immunotherapies on the horizon for relapsed/refractory multiple myeloma [J].
Braunstein, Marc ;
Weltz, Jonathan ;
Davies, Faith .
EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (04) :377-389
[23]   New horizons in our understanding of precursor multiple myeloma and early interception [J].
dos Santos, David M. Cordas ;
Toenges, Rosa ;
Bertamini, Luca ;
Alberge, Jean-Baptiste ;
Ghobrial, Irene M. .
NATURE REVIEWS CANCER, 2024, 24 (12) :867-886
[24]   Multiple Myeloma Unpacked [J].
Gay, Francesca ;
Marchetti, Edoardo ;
Bertuglia, Giuseppe .
HEMATOLOGICAL ONCOLOGY, 2025, 43
[25]   Current Novel Targeted Therapeutic Strategies in Multiple Myeloma [J].
Lin, Cindy Hsin-Ti ;
Tariq, Muhammad Junaid ;
Ullah, Fauzia ;
Sannareddy, Aishwarya ;
Khalid, Farhan ;
Abbas, Hasan ;
Bader, Abbas ;
Samaras, Christy ;
Valent, Jason ;
Khouri, Jack ;
Anwer, Faiz ;
Raza, Shahzad ;
Dima, Danai .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[26]   Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/ refractory multiple myeloma: US Myeloma Immunotherapy Consortium real world experience [J].
Hashmi, Hamza ;
Hansen, Doris K. ;
Peres, Lauren C. ;
Puglianini, Omar Castaneda ;
Freeman, Ciara ;
De Avila, Gabriel ;
Sidana, Surbhi ;
Shune, Leyla ;
Sborov, Douglas W. ;
Davis, James ;
Wagner, Charlotte ;
Kocoglu, Mehmet H. ;
Atrash, Shebli ;
Voorhees, Peter ;
Simmons, Gary ;
Ferreri, Christopher ;
Kalariya, Nilesh ;
Anderson, Larry D., Jr. ;
Afrough, Aimaz ;
Dima, Danai ;
Khouri, Jack ;
McGuirk, Joseph ;
Locke, Frederick L. ;
Baz, Rachid ;
Patel, Krina K. ;
Alsina, Melissa .
HAEMATOLOGICA, 2024, 109 (05) :1514-1524
[27]   Immune status and selection of patients for immunotherapy in myeloma: a proposal [J].
V. Dhodapkar, Madhav .
BLOOD ADVANCES, 2024, 8 (10) :2424-2432
[28]   IgG replacement in multiple myeloma [J].
Wonnaparhown, Alex ;
Hilal, Talal ;
Squire, Jacqueline ;
Freeman, Catherine ;
Fonseca, Rafael .
BLOOD CANCER JOURNAL, 2024, 14 (01)
[29]   Novel immunotherapies in multiple myeloma [J].
Ohmine, Ken ;
Uchibori, Ryosuke .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (06) :799-810
[30]   Introduction to "Immunotherapies for Multiple Myeloma" [J].
Offidani, Massimo ;
Petrucci, Maria Teresa .
PHARMACEUTICALS, 2020, 13 (11)